Pharmacogenomics of CRC treatments: putting bricks on the path to personalized medicine

Similar Items

• Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations?
  od: Gómez-Fernández, Nuria, i dr.
  Izdano: (2009)
• Single Nucleotide Polymorphisms in the Wnt and BMP Pathways and Colorectal Cancer Risk in a Spanish Cohort
  od: Fernández-Rozadilla, Ceres, i dr.
  Izdano: (2010)
• The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?
  od: Simões, Ana Rita, i dr.
  Izdano: (2020)
• Identification of Lynch syndrome: How should we proceed in the 21(st) century?
  od: Castells, Antoni, i dr.
  Izdano: (2007)
• A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12
  od: Fernandez-Rozadilla, Ceres, i dr.
  Izdano: (2013)